Cargando…
Correlation of HER2/neu antibody response to clinical response in a Phase II trial of the ae37+gm-csf her2 peptide vaccine
| Autores principales: | , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288771/ http://dx.doi.org/10.1186/2051-1426-2-S3-P90 |
| _version_ | 1782352021042495488 |
|---|---|
| author | Greene, Julia Schneble, Erika Martin, Jonathan Flores, Maddie Trappey, Alfred Berry, John Vreeland, Timothy Hale, Diane Clifton, Guy Perez, Sonia A Papamichail, Michael Peoples, George Mittendorf, Elizabeth Ponniah, Sathibalan |
| author_facet | Greene, Julia Schneble, Erika Martin, Jonathan Flores, Maddie Trappey, Alfred Berry, John Vreeland, Timothy Hale, Diane Clifton, Guy Perez, Sonia A Papamichail, Michael Peoples, George Mittendorf, Elizabeth Ponniah, Sathibalan |
| author_sort | Greene, Julia |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4288771 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2014 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-42887712015-01-15 Correlation of HER2/neu antibody response to clinical response in a Phase II trial of the ae37+gm-csf her2 peptide vaccine Greene, Julia Schneble, Erika Martin, Jonathan Flores, Maddie Trappey, Alfred Berry, John Vreeland, Timothy Hale, Diane Clifton, Guy Perez, Sonia A Papamichail, Michael Peoples, George Mittendorf, Elizabeth Ponniah, Sathibalan J Immunother Cancer Poster Presentation BioMed Central 2014-11-06 /pmc/articles/PMC4288771/ http://dx.doi.org/10.1186/2051-1426-2-S3-P90 Text en Copyright © 2014 Greene et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Poster Presentation Greene, Julia Schneble, Erika Martin, Jonathan Flores, Maddie Trappey, Alfred Berry, John Vreeland, Timothy Hale, Diane Clifton, Guy Perez, Sonia A Papamichail, Michael Peoples, George Mittendorf, Elizabeth Ponniah, Sathibalan Correlation of HER2/neu antibody response to clinical response in a Phase II trial of the ae37+gm-csf her2 peptide vaccine |
| title | Correlation of HER2/neu antibody response to clinical response in a Phase II trial of the ae37+gm-csf her2 peptide vaccine |
| title_full | Correlation of HER2/neu antibody response to clinical response in a Phase II trial of the ae37+gm-csf her2 peptide vaccine |
| title_fullStr | Correlation of HER2/neu antibody response to clinical response in a Phase II trial of the ae37+gm-csf her2 peptide vaccine |
| title_full_unstemmed | Correlation of HER2/neu antibody response to clinical response in a Phase II trial of the ae37+gm-csf her2 peptide vaccine |
| title_short | Correlation of HER2/neu antibody response to clinical response in a Phase II trial of the ae37+gm-csf her2 peptide vaccine |
| title_sort | correlation of her2/neu antibody response to clinical response in a phase ii trial of the ae37+gm-csf her2 peptide vaccine |
| topic | Poster Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288771/ http://dx.doi.org/10.1186/2051-1426-2-S3-P90 |
| work_keys_str_mv | AT greenejulia correlationofher2neuantibodyresponsetoclinicalresponseinaphaseiitrialoftheae37gmcsfher2peptidevaccine AT schnebleerika correlationofher2neuantibodyresponsetoclinicalresponseinaphaseiitrialoftheae37gmcsfher2peptidevaccine AT martinjonathan correlationofher2neuantibodyresponsetoclinicalresponseinaphaseiitrialoftheae37gmcsfher2peptidevaccine AT floresmaddie correlationofher2neuantibodyresponsetoclinicalresponseinaphaseiitrialoftheae37gmcsfher2peptidevaccine AT trappeyalfred correlationofher2neuantibodyresponsetoclinicalresponseinaphaseiitrialoftheae37gmcsfher2peptidevaccine AT berryjohn correlationofher2neuantibodyresponsetoclinicalresponseinaphaseiitrialoftheae37gmcsfher2peptidevaccine AT vreelandtimothy correlationofher2neuantibodyresponsetoclinicalresponseinaphaseiitrialoftheae37gmcsfher2peptidevaccine AT halediane correlationofher2neuantibodyresponsetoclinicalresponseinaphaseiitrialoftheae37gmcsfher2peptidevaccine AT cliftonguy correlationofher2neuantibodyresponsetoclinicalresponseinaphaseiitrialoftheae37gmcsfher2peptidevaccine AT perezsoniaa correlationofher2neuantibodyresponsetoclinicalresponseinaphaseiitrialoftheae37gmcsfher2peptidevaccine AT papamichailmichael correlationofher2neuantibodyresponsetoclinicalresponseinaphaseiitrialoftheae37gmcsfher2peptidevaccine AT peoplesgeorge correlationofher2neuantibodyresponsetoclinicalresponseinaphaseiitrialoftheae37gmcsfher2peptidevaccine AT mittendorfelizabeth correlationofher2neuantibodyresponsetoclinicalresponseinaphaseiitrialoftheae37gmcsfher2peptidevaccine AT ponniahsathibalan correlationofher2neuantibodyresponsetoclinicalresponseinaphaseiitrialoftheae37gmcsfher2peptidevaccine |